ArticleFrontiers in oncology2022

Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis.

Jong Keon Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.